GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipocine Inc (STU:2VT0) » Definitions » Cyclically Adjusted PB Ratio

Lipocine (STU:2VT0) Cyclically Adjusted PB Ratio : 0.13 (As of Apr. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Lipocine Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Lipocine's current share price is €3.944. Lipocine's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €30.15. Lipocine's Cyclically Adjusted PB Ratio for today is 0.13.

The historical rank and industry rank for Lipocine's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:2VT0' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.31   Max: 1.48
Current: 0.21

During the past years, Lipocine's highest Cyclically Adjusted PB Ratio was 1.48. The lowest was 0.10. And the median was 0.31.

STU:2VT0's Cyclically Adjusted PB Ratio is ranked better than
82.06% of 641 companies
in the Biotechnology industry
Industry Median: 1.72 vs STU:2VT0: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lipocine's adjusted book value per share data for the three months ended in Dec. 2023 was €3.514. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €30.15 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lipocine Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lipocine's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipocine Cyclically Adjusted PB Ratio Chart

Lipocine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.79 0.29 0.13

Lipocine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.22 0.20 0.13 0.13

Competitive Comparison of Lipocine's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Lipocine's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipocine's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipocine's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lipocine's Cyclically Adjusted PB Ratio falls into.



Lipocine Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lipocine's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.944/30.15
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipocine's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Lipocine's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.514/129.4194*129.4194
=3.514

Current CPI (Dec. 2023) = 129.4194.

Lipocine Quarterly Data

Book Value per Share CPI Adj_Book
201403 39.109 99.695 50.770
201406 33.120 100.560 42.625
201409 30.930 100.428 39.859
201412 28.404 99.070 37.105
201503 29.008 99.621 37.685
201506 43.387 100.684 55.770
201509 38.399 100.392 49.502
201512 35.912 99.792 46.574
201603 29.927 100.470 38.550
201606 25.501 101.688 32.455
201609 23.220 101.861 29.502
201612 22.718 101.863 28.864
201703 20.529 102.862 25.829
201706 18.487 103.349 23.150
201709 16.008 104.136 19.895
201712 12.822 104.011 15.954
201803 10.809 105.290 13.286
201806 9.497 106.317 11.561
201809 8.032 106.507 9.760
201812 6.487 105.998 7.920
201903 7.685 107.251 9.274
201906 5.994 108.070 7.178
201909 4.629 108.329 5.530
201912 2.555 108.420 3.050
202003 2.107 108.902 2.504
202006 3.218 108.767 3.829
202009 3.188 109.815 3.757
202012 3.061 109.897 3.605
202103 6.856 111.754 7.940
202106 5.713 114.631 6.450
202109 5.370 115.734 6.005
202112 7.765 117.630 8.543
202203 7.397 121.301 7.892
202206 7.248 125.017 7.503
202209 7.303 125.227 7.548
202212 6.461 125.222 6.678
202303 5.733 127.348 5.826
202306 5.034 128.729 5.061
202309 3.963 129.860 3.950
202312 3.514 129.419 3.514

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lipocine  (STU:2VT0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lipocine Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lipocine's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipocine (STU:2VT0) Business Description

Industry
Traded in Other Exchanges
Address
675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

Lipocine (STU:2VT0) Headlines

No Headlines